Skip to content

Hallucinogen Persisting Perception Disorder and Risk of Suicide.

Joy Brodrick, Brian G Mitchell

Journal of pharmacy practice August 2016 DOI: 10.1177/0897190014566314 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population A 30-year-old male patient with hallucinogen persisting perception disorder after cannabis laced with PCP or LSD
Keywords Death Hallucinogen Mortality Suicide
Key findings The authors describe a 30-year-old man who developed HPPD after smoking cannabis laced with PCP or LSD roughly 10 years earlier and later died by suicide following psychiatric treatment and discharge. They suggest HPPD may be significantly underdiagnosed and undertreated, and that missed or inadequate care can perpetuate years of suffering and contribute to severe depression and suicide.

Abstract

A 30-year-old male patient developed a hallucinogen persisting perception disorder (HPPD) after smoking cannabis laced with phencyclidine (PCP) or lysergic acid diethylamide (LSD) 10 years prior to hospital admission. Clinically, he reported seeing vivid, saturated colors and caricature-like objects. The patient described perceiving objects or people in motion as moving faster than normal. He reported living in a dream-like state and feeling numb and detached from other people and his surroundings. Upon pharmacotherapy initiation, facility transfer, and subsequent discharge from an acute psychiatry unit, he ultimately committed suicide. Although hallucinogen abuse is common in the United States, this case suggests that HPPD maybe significantly underdiagnosed and undertreated. In some cases, this oversight may perpetuate years of unnecessary patient suffering and can ultimately lead to severe depression and suicide.

Citations in the library

Explore topics